Antimicrobial drug susceptibility of Staphylococcus intermedius clinical isolates from canine pyoderma

Journal of Veterinary Medicine Series B: Infectious Diseases and Veterinary Public Health

Volumn 52, Issue 1, 2005, Pages 25-31

  Ganiere, J P ^a   Medaille, C ^a,b   Mangion, C ^a  

^a U de Pathologie Infectieuse   (France)

^b LABORATOIRE VÉBIOTEL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; ARTICLE; DOG; DOG DISEASE; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PYODERMA; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; DOG DISEASES; DOGS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; PYODERMA; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS;

STAPHYLOCOCCUS INTERMEDIUS;

EID: 14644440905     PISSN: 09311793     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0450.2004.00816.x     Document Type: Article

References (51)

1. Barrs, V. R., R. Malik, and D. N. Love, 1995: Antimicrobial susceptibility of staphylococci isolated from various disease conditions in dogs: a further survey. Aust. Vet. Pract. 25, 37-42.
2. Boerlin, P., A. P. Burnens, J. Frey, P. Kuhnert, and J. Nicolet, 2001: Molecular epidemiology and genetic linkage of macrolide and aminoglycoside resistance in Staphylococcus intermedius of canine origin. Vet. Microbiol. 79, 155-169.
3. Carlotti, D. N., 1996: New trends in systemic antibiotherapy of bacterial skin disease in dogs. Suppl. Compend. Contin. Educ. Pract. Vet. 18, 40-47.
4. Carlotti, D. N., E. Guaguere, D. Pin, P. Jasmin, E. Thomas, and V. Guiral, 1999: Therapy of difficult cases of canine pyoderma with marbofloxacin: a report of 39 dogs. J. Small Anim. Pract. 40, 265-270.
5. Codner, E. C., 1988: Choosing a treatment course for dogs with pyoderma. Vet. Med. 83, 995-1003.
6. Coelho-Baptista, B., M. Costa, J. Duarte-Correia, and C. Pomba, 2003: In vitro activity of enrofloxacin, marbofloxacin, orbifloxacin and ciprofloxacin against clinical strains of Staphylococcus intermedius isolated from dogs in Portugal. J. Vet. Pharmacol. Ther. 26 (Suppl. 1), 155-156.
7. Comité de l'Antibiogramme de la Sociėté Française de Microbiologie (CA-SFM), 1993: Méthode de dėtermination de la CMI en milieu solide pour les bactéries aérobies ȧ croissance rapide. Bull. Soc. Fr. Microbiol. 8, 156-161.
8. Comité de l'Antibiogramme de la Sociėté Française de Microbiologie (CA-SFM), 2004: Communiquė 2004. http://www.sfm.asso.fr (accessed 1 February 2004).
9. Cox, H. T., S. Newman, A. F. Roy, and J. D. Hoskins, 1984: Species of Staphylococcus isolated from animal infections. Cornell Vet. 74, 124-135.
10. Cox, H. T., J. D. Hoskins, S. Newman, C. S. Foil, G. H. Turnwald, and A. F. Roy, 1988: Temporal study of staphylococcal species on healthy dogs. Am. J. Vet. Res. 49, 747-751.
11. Dowling, P. M., 1996: Antimicrobial therapy of skin and ear infections. Can. Vet. J. 37, 695-699.
12. Ganière, J.-P., C. Médaille, A. Limet, N. Ruvoen, and G. André-Fontaine, 2001: Antimicrobial activity of enrofloxacin against Staphylococcus intermedius strains isolated from canine pyodermas. Vet. Dermatol. 12, 171-175.
13. Ganière, J.-P., C. Médaille, and F. Etorė, 2004: In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections. Res. Vet. Sci. 77, 67-71.
14. Goodacre, R., R. Harvey, S. A. Howell, L. W. Greenham, and W. C. Noble, 1997: An epidemiological study of Staphylococcus intermedius strains isolated from dogs, their owners and veterinary surgeons. J. Anal. Appl. Pyrol. 44, 49-64.
15. Gortel, K., K. L. Campbell, I. Kakoma, T. Whittem, D. J. Schaeffer, and R. M. Weisiger, 1996: Methicillin resistance among staphylococci isolated from dogs. Am. J. Vet. Res. 60, 1526-1530.
16. Greene, R. T., and S. Schwarz, 1992: Small antibiotic resistance plasmids in Staphylococcus intermedius. Zbl. Bakt. 276, 380-389.
17. Guardabassi, L., M. E. Loeber, and A. Jacobson, 2004: Transmission of multiple antimicrobial-resistant Staphylococcus intermedius between dogs affected by deep pyoderma and their owners. Vet. Microbiol. 98, 23-27.
18. Harvey, R. G., R. R. Marples, and W. C. Noble, 1994: Nasal carriage of Staphylococcus intermedius in humans in contact with dogs. Microbiol. Ecol. Health Dis. 7, 225-227.
19. Hesselbarth, J., C. Werckenthin, B. Liebisch, and S. Schwarz, 1995: Insertion elements in Staphylococcus intermedius. Lett. Appl. Microbiol. 20, 180-183.
20. Holm, B. R., U. Petersson, A. Mörner, K. Bergström, A. Franklin, and C. Greko, 2002: Antimicrobial resistance in staphylococci from canine pyoderma: a prospective study of first-time and recurrent cases in Sweden. Vet. Rec. 151, 600-605.
21. Hooper, D. C., 2002: Fluoroquinolone resistance among gram-positive cocci. Lancet Infect. Dis. 2, 530-538.
22. Hoskins, J. D., S. Newman, A. F. Roy, C. S. Foil, and H. T. Cox, 1985: Detection of β-lactamase produced by Staphylococcus intermedius. Am. J. Vet. Res. 46, 1526-1528.
23. Ihrke, P. J., 1987: An overview of bacterial skin diseases in the dog. Br. Vet. J. 143, 112-118.
24. Ihrke, P. J., G. Papich, and T. C. Demanuelle, 1999: The use of fluoroquinolones in veterinary dermatology. Vet. Dermatol. 10, 193-204.
25. Kehrenberg, C., and S. Schwarz, 2004: fexA, a novel Staphylococcus lentus gene encoding resistance to florfenicol and chloramphenicol. Antimicrob. Agents Chemother. 48, 615-618.
26. Kruse, H., M. Hofshagen, S. I. Thoresen, W. P. Bredal, I. Vollset, and N. E. Søli, 1996: The antimicrobial susceptibility of Staphylococcus species isolated from canine dermatitis. Vet. Res. Commun. 20, 205-214.
27. Lloyd, D., R. P. Allaker, and A. L. Pattinson, 1991: Carriage of Staphylococcus intermedius on the ventral abdomen of clinically normal dogs and those with pyoderma. Vet. Dermatol. 2, 161-164.
28. Lloyd, D., A. I. Lamport, and C. Feeney, 1996: Sensitivity to antibiotics amongst cutaneous and mucosal isolates of canine pathogenic staphylococci in the UK 1980-96. Vet. Dermatol. 7, 171-175.
29. Lloyd, D., A. I. Lamport, W. C. Noble, and S. A. Howell, 1999: Fluoroquinolone resistance in Staphylococcus intermedius. Vet. Dermatol. 10, 193-204.
30. Mason, I. S., and M. Kietzmann, 1999: Cephalosporins - pharmacological basis of clinical use in veterinary dermatology. Vet. Dermatol. 10, 187-192.
31. Medleau, L., R. E. Long, J. Brown, and W. H. Miller, 1986: Frequency and antimicrobial susceptibility of Staphylococcus species isolated from canine pyodermas. Am. J. Vet. Res. 47, 229-231.
32. National Committee for Clinical Laboratory Standards (NCCLS), 2002: Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. Approved Standard, 2nd edn, NCCLS Document. pp. M31-A2. Wayne, Pennsylvania, USA.
33. Noble, W. C., and L. E. Kent, 1992: Antibiotic resistance in Staphylococcus intermedius isolated from cases of pyoderma in the dog. Vet. Dermatol. 3, 71-74.
34. Noli, C., and D. Boothe, 1999: Macrolides and lincosamides. Vet. Dermatol. 10, 217-223.
35. Normand, E. H., N. R. Gibson, D. J. Taylor, S. Carmichael, and S. W. J. Reid, 2000: Trends of antimicrobial resistance in bacterial isolates from a small animal referral hospital. Vet. Rec. 146, 151-155.
36. Pellerin, J. L., P. Bourdeau, H. Sebbag, and J. M. Person, 1997: Epidemiosurveillance of antimicrobial compound resistance of Staphylococcus intermedius clinical isolates from canine pyodermas. Comp. Immunol. Microbiol. Infect. Dis. 21, 115-133.
37. Petersen, A. D., R. D. Walker, M. M. Bowman, and E. J. Rosser, 2002: Frequency of isolation and antimicrobial susceptibility patterns of Staphylococcus intermedius and Pseudomonas aeruginosa isolates from canine skin and ear samples over a 6-year period (1992-1997). J. Am. Anim. Hosp. Assoc. 38, 407-413.
38. Piddock, L. J. V., 1994: New quinolones and gram-positive bacteria. Antimicrob. Agents Chemother. 38, 163-169.
39. Prescott, J. F., W. J. Hanna, R. Reid-Smith, and K. Drost, 2002: Antimicrobial drug use and resistance in dogs. Can. Vet. J. 43, 107-116.
40. Schäfer-Somi, S., J. Spergser, J. Breitenfellner, and J. E. Aurich, 2003: Bacterial status of canine milk and septicaemia in neonatal puppies - a retrospective study. J. Vet. Med. B 50, 343-346.
41. Schmilz, F. J., P. G. Higgins, S. Mayer, A. C. Fluit, and A. Dalhoff, 2002: Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance. Eur. J. Clin. Microbiol. Infect. Dis. 21, 647-659.
42. Schwarz, S., and Z. Wang, 1993: Tetracycline resistance in Staphylococcus intermedius. Lett. Appl. Microbiol. 17, 88-91.
43. Schwarz, S., C. Werckenthin, L. Pinter, L. E. Kent, and W. C. Noble, 1995: Chloramphenicol resistance in Staphylococcus intermedius from a single veterinary centre: evidence for plasmid and chromosomal location of the resistance genes. Vet. Microbiol. 43, 151-159.
44. Schwarz, S., M. C. Roberts, C. Werckenthin, Y. Pang, and C. Lange, 1998: Tetracycline resistance in Staphylococcus spp. from domestic animals. Vet. Microbiol. 63, 217-227.
45. Schwarz, S., C. Werckenthin, and C. Kehrenberg, 2000: Identification of a plasmid-borne chloramphenicol-florfenicol resistance gene in Staphylococcus sciuri. Antimicrob. Agents Chemother. 44, 2530-2533.
46. Scott, D. W., 1997: Enrofloxacin-resistant S. intermedius [Letter]. Vet. Dermatol. 8, 144.
47. Shimizu, A., Y. Wakita, S. Nagase, M. Okabe, T. Koji, T. Hayashi, N. Nagase, A. Sasaki, J. Kawano, K. Yamashita, and M. Takagi, 2001: Antimicrobial susceptibility of Staphylococcus intermedius isolated from healthy and diseased dogs. J. Vet. Med. Sci. 63, 357-360.
48. Speer, B. S., N. B. Shoemaker, and A. A. Salyers, 1992: Bacterial resistance to tetracycline: mechanism, transfer, and clinical significance. Clin. Microbiol. Rev. 5, 387-389.
49. Stephan, B., K. Hellmann, P. Liège, S. Granier, T. N. Knoppe, E. Heinen, and H. A. Greife, 2003: Clinical efficacy and safety of pradofloxacin in the treatment of canine pyoderma and wound infections under field conditions. J. Vet. Pharmacol. Ther. 26 (Suppl. 1), 160-161.
50. Walker, R. D., and C. Thornsberry, 1998: Decrease in antibiotic susceptibility or increase in resistance? J. Antimicrob. Chemother. 41, 1-4.
51. Werckenthin, C., M. Cardoso, J. L. Martel, and S. Schwarz, 2001: Antimicrobial resistance in staphylococci from animals with particular reference to bovine Staphylococcus aureus, porcine Staphylococcus hyicus, and canine Staphylococcus intermedius. Vet. Res. 32, 341-362.